跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
METFORMIN TABLETS - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
METFORMIN TABLETS
Authorized
STANDARD
METFORMIN TABLETS
GRANULES INDIA LIMITED
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
7475b4c020219b6c
Company
GRANULES INDIA LIMITED
Type
Standard
Approval Details
Approval Id
7475b4c020219b6c
Drug Approval Canada Name
METFORMIN TABLETS
Product Name
METFORMIN TABLETS
Status
Marketed
Status Date
2022-02-04
Original Market Date
2022-02-04
Din
02514494
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
68:20.04
Atc Original
A10BA02 METFORMIN
Atc Name
a 10 ba 02
Aig Number
0101773002
Company Name
GRANULES INDIA LIMITED
Company Address
2nd Floor, 3rd Block, My Home Hub, Madhapur-Hyderabad, Telangana, India, 500081
Company Detail Path
/organization/granules-india-limited
Company Information
Pharmaceutical Company Name
GRANULES INDIA LIMITED
Country Name
India
Province Name
Andhra Pradesh
City Name
anakapalli,andhra pradesh,country_in
Address
Unit-IV, Plot No.08, Jawaharlal Nehru Pharma City
Active Ingredients
METFORMIN HYDROCHLORIDE
850 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
7475b4c020219b6c
Type
Standard
Back to Health Canada Approvals